Xylem Inc. (NYSE:XYL) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Xylem Inc. (NYSE:XYLGet Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen analysts that are currently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $153.5385.

XYL has been the topic of several recent research reports. Jefferies Financial Group raised Xylem from a “hold” rating to a “buy” rating and increased their target price for the company from $130.00 to $140.00 in a research report on Thursday. Oppenheimer cut their target price on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 29th. Stifel Nicolaus cut their target price on Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Barclays cut their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 29th. Finally, UBS Group upped their price target on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th.

Get Our Latest Analysis on XYL

Xylem Stock Performance

NYSE:XYL opened at $116.77 on Tuesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. Xylem has a 1 year low of $105.29 and a 1 year high of $154.27. The stock’s 50 day simple moving average is $112.88 and its two-hundred day simple moving average is $125.15. The company has a market cap of $27.75 billion, a price-to-earnings ratio of 29.05, a PEG ratio of 1.66 and a beta of 1.05.

Xylem (NYSE:XYLGet Free Report) last released its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. The business had revenue of $2.13 billion for the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The company’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, equities analysts anticipate that Xylem will post 5.51 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were paid a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. Xylem’s payout ratio is 42.79%.

Insider Transactions at Xylem

In other news, Director Jerome A. Peribere bought 1,210 shares of Xylem stock in a transaction on Monday, May 4th. The shares were bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the purchase, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.32% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Militia Capital Management LLC purchased a new position in shares of Xylem in the first quarter valued at approximately $311,000. Pine Valley Investments Ltd Liability Co boosted its stake in shares of Xylem by 34.1% in the first quarter. Pine Valley Investments Ltd Liability Co now owns 2,046 shares of the industrial products company’s stock valued at $244,000 after purchasing an additional 520 shares during the period. DV Trading LLC purchased a new position in shares of Xylem in the first quarter valued at approximately $239,000. Allen Capital Group LLC raised its holdings in Xylem by 13.2% in the first quarter. Allen Capital Group LLC now owns 6,300 shares of the industrial products company’s stock valued at $753,000 after acquiring an additional 734 shares in the last quarter. Finally, Segall Bryant & Hamill LLC acquired a new stake in Xylem in the first quarter valued at approximately $231,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Xylem

(Get Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

See Also

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.